Literature DB >> 11554387

The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.

P K Duffner1, M E Horowitz, J P Krischer, P C Burger, M E Cohen, R A Sanford, H S Friedman, L E Kun.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 11554387      PMCID： PMC1920752          DOI： 10.1093/neuonc/1.2.152

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  57 in total

1.  Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.

Authors:  André O von Bueren; Katja von Hoff; Torsten Pietsch; Nicolas U Gerber; Monika Warmuth-Metz; Frank Deinlein; Isabella Zwiener; Andreas Faldum; Gudrun Fleischhack; Martin Benesch; Juergen Krauss; Joachim Kuehl; Rolf D Kortmann; Stefan Rutkowski
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

2.  ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration.

Authors:  Liangping Yuan; Mariarita Santi; Elisabeth J Rushing; Robert Cornelison; Tobey J MacDonald
Journal:  Clin Exp Metastasis       Date:  2010-06-06       Impact factor: 5.150

Review 3.  Paediatric and adult malignant glioma: close relatives or distant cousins?

Authors:  Chris Jones; Lara Perryman; Darren Hargrave
Journal:  Nat Rev Clin Oncol       Date:  2012-05-29       Impact factor: 66.675

4.  Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.

Authors:  Douglas R Strother; Lucie Lafay-Cousin; James M Boyett; Peter Burger; Patricia Aronin; Louis Constine; Patricia Duffner; Mehmet Kocak; Larry E Kun; Marc E Horowitz; Amar Gajjar
Journal:  Neuro Oncol       Date:  2013-12-12       Impact factor: 12.300

Review 5.  Embryonic tumours of the central nervous system.

Authors:  Aurora Navajas Gutiérrez; Ana Fernández-Teijeiro Alvarez
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

6.  Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.

Authors:  Anthony P Y Liu; Camden Hastings; Shengjie Wu; Johnnie K Bass; Andrew M Heitzer; Jason Ashford; Robert Vestal; Mary E Hoehn; Yahya Ghazwani; Sahaja Acharya; Heather M Conklin; Frederick Boop; Thomas E Merchant; Amar Gajjar; Ibrahim Qaddoumi
Journal:  Cancer       Date:  2019-01-08       Impact factor: 6.860

Review 7.  Chemotherapy for malignant brain tumors of childhood.

Authors:  Nicholas G Gottardo; Amar Gajjar
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

8.  Brain tumors in children under 1 year of age: emphasis on the relationship of prognostic factors.

Authors:  Roberto Rivera-Luna; Aurora Medina-Sanson; Carlos Leal-Leal; Francisco Pantoja-Guillen; Marta Zapata-Tarrés; Rocio Cardenas-Cardos; Rafael Barrera-Gómez; Fernando Rueda-Franco
Journal:  Childs Nerv Syst       Date:  2003-05-06       Impact factor: 1.475

9.  Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.

Authors:  Carsten Friedrich; André O von Bueren; Katja von Hoff; Nicolas U Gerber; Holger Ottensmeier; Frank Deinlein; Martin Benesch; Robert Kwiecien; Torsten Pietsch; Monika Warmuth-Metz; Andreas Faldum; Joachim Kuehl; Rolf D Kortmann; Stefan Rutkowski
Journal:  Neuro Oncol       Date:  2012-12-07       Impact factor: 12.300

Review 10.  Proton therapy for paediatric CNS tumours - improving treatment-related outcomes.

Authors:  Vinai Gondi; Torunn I Yock; Minesh P Mehta
Journal:  Nat Rev Neurol       Date:  2016-05-20       Impact factor: 42.937
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.